Hello,
First a question: Who would like to present on Thursday's analysis group
call? Next week we should discuss splicing QTLs (with results from Jean
and myself), but this week's slot is free.
Then a couple of analysis updates:
- I've done some analysis on miRNA-mRNA interactions; namely on whether
miRNA-cis-eQTLs show increased trans-signal to the targets of these
miRNAs. The answer is maybe yes - the signal is small but significant.
See http://sanabre.net/geuvadis/index.php/MiRNA-mRNA_interaction .
- I've updated some normalizations of quantifications - I let some of
you know about these already during the weekend, but for FYI for
eneryone. Details in
http://sanabre.net/geuvadis/index.php/Basic_methodology#Normalization_of_th…
. These are quantifications done jointly on the 462 samples by PEER, and
then transforming the residuals to standard normal (*norm* in the
filename). There are files for miRNAs (full and seed-pooled), exons,
splice junctions, introns, and transcripts in the directories below:
/upload/geuvadis/wp4_rnaseq/main_project/analysis_data/mirna/quantification_tables
/upload/geuvadis/wp4_rnaseq/main_project/analysis_data/quantification/exon/
/upload/geuvadis/wp4_rnaseq/main_project/analysis_data/quantification/splice_junction-intron
/upload/geuvadis/wp4_rnaseq/main_project/analysis_data/quantification/splice_junction-intron
/upload/geuvadis/wp4_rnaseq/main_project/analysis_data/quantification/transcript
cheers,
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
Hello,
In order to keep things rolling for the main paper, I've put together a
list of action items for all of us, as well as an early draft of
supplemental figures and tables. The main figure draft has been updated
a bit as well.
There are plenty of placeholders for us to fill, and let's discuss these
on the call tomorrow - these are definitely open for discussion. I'd
also like to emphasize that now when we're finalizing the analysis and
I'm trying my best to put it all together, we should have subgroup or
one-on-one calls if you don't understand what I'm asking from you, or if
it seems that I'm misunderstanding your analysis.
best,
Tuuli
The action items are here (as well as in the attached document):
Everyone
- Text for the supplement: methods, results, and conclusions of your
analysis.
- Good-quality figures (see doc for details)
- Deadline: October 20
Tuuli
- finish splicing QTLs
- plenty of downstream analysis of QTLs
- rare variant mapping
- Loss-of-function ASE NMD stats
- ASAS / ASE sharing analysis
- finish some QC analyses
- ...a zillion other things
Micha
- Coordinate documentation of mRNA mapping and transcript quantification
- Coordinate splicing paper
- some plot(s) of splicing variation (coefficient of variation?
Annotated/novel junctions vs population freq?)
- Final figures:
- gene discovery plot that works in smaller space
- splice score distributions
- allele frequency distributions for splicing score categories (DAF from
annotations in vcf)
Marc
- miRNA-mRNA correlation analysis
Jean
- quantitative analysis of population differences (e.g. GBR-CEU looks
visually the same as GBR-YRI, but is this really true numerically?
Compare all population pairs)
- prettier figures of transcript quantification stats
- prettier figures of quantitative vs qualitative variation
Mar & Pedro
- Prepare a Venn-diagram of splice/expression differentiated genes and
plot some examples
Liliana
- quantitative values of fusion events for QTL analysis
- prettier frequency and distance plots
Manny
- Stop-gained NMD compensation
- Splice effect modeling with Micha's scores
- NMD prediction
- Coordinate LoF paper
Peter
- coordinate QC paper
Irina
- results of repeat analysis
- quantitative values for QTL analysis?
Maarten
- miRNA-mRNA correlation analysis
Matthias
- prettier plots that illustrate soft splicing variation:
- phenomenon in general: the lineplot that shows the distances from the
major spliceoform
- population variation in an analogous way to Jean's analysis
Daniela
- results of n-TAR analysis
- quantitative values of n-TARs for QTL analysis
Thomas
- results of RNA editing analysis
- quantitative values of editing for QTL analysis
Monkol & Daniel
- annotation statistics (variants in each category)
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
This is to remind you that the deadline for the survey is tomorrow. Here are the results so far per country:
Denmark 1
Estonia 1
France 2
Germany 4
Ireland 1
Slovenia 1
Spain 8
Sweden 6
Switzerland 7
the Netherlands 5
Turkey 4
We still have no response from many European countries, which lowers the value of our survey.
Please get in touch with me if you know specific people who have not filled in the survey and can do so quickly.
You'll find the names of the institutes who have answered below,
Kind regards,
Gabrielle
Dept. Medical Sciences, Molecular Medicine
national centre for medical genetics
The EStonian Genome Center of University of Tartu
Diagnostikcentrum, Clinical Pathology and Clinical Genetics
University of Lausanne
CHUV
Uppsala University; SNP&SEQ Technology platform + Uppsala Genome Center
University Hospital Copenhagen
Institute of Medical Genetics at the University of Zurich
Kantonsspital Olten
Division of Human Genetics
Leiden University Medical Center
Center for Human Genetics and Laboratory Medicine
Institut Central des Hopitaux Valaisans-RSV
Humangenetics
İstanbul University Institute of Experimental Medicine
Max Planck Institute for Molecular Genetics
UMC Utrecht
Leiden University Medical Center
TUBITAK, MAM, Genetic Engineering and Biotechnology Institute
VUMC
Lund University Diabetes Centre
Science For Life Laboratory
Department of Medical genetics & Inserm U 910
Helmholtz Zentrum Zentrum München
Hôpital Timone Enfants et faculté de Médecine
Center for Genomic Regulation
INGEMM
Fundacion Investigación Clínico de Valencia-INCLIVA
Instituto de Salud Carlos III
Uppsala University. Immunology, Genetics and Pathology / SciLifeLab
Hospital Universitario Ramon y Cajal
Hospital de Terrassa
Complexo Hospitalario Universitario de Santiago
Clinical institute of medical genetics Ljubljana
Maastricht UMC+, Department of Clinical Genetics
Sabanci University
Institute of Medical Genetics and Applied Genomics, University of Tuebingen
Hospital San Pedro de Alcántara
TUBITAK-BILGEM
From: Gabrielle Anne Bertier
Sent: 28 September, 2012 18:12 PM
To: 'geuvadis_partners(a)lists.crg.es'; 'geuvadis_exome(a)lists.crg.es'; 'geuvadis_wpl(a)lists.crg.es'; 'geuvadis_rnaseq(a)lists.crg.es'; 'geuvadis_rna_analysis(a)lists.crg.es'
Cc: Xavier Estivill; Michela Bertero; 'Bea Sobrino'
Subject: IMPORTANT NOTICE: GEUVADIS survey DEADLINE EXTENDED
Dear all,
I remind you that we would highly appreciate if you could fill in, and distribute our survey on NGS to all your relevant colleagues.
Note that we've extended the deadline to the 10th October 2012
Full survey link:
https://qtrial.qualtrics.com/SE/?SID=SV_bHJDue550PwdFrv
To describe the survey please use freely the following text:
------------------
THE GEUVADIS PROJECT - More information on our website: www.geuvadis.eu<file:///C:\Users\gbertier\Documents\GEUVADIS\Annual%20Meeting%202\www.geuvadis.eu>
The latest high-throughput next-generation sequencing technologies allow investigators to sequence entire human genomes and transcriptomes at an affordable price and within a short time frame. An increasing number of research centers in Europe have access to these technologies, in-house or through regional, national and international infrastructures. Storing, disseminating and analysing the large amount of data produced generate major challenges. Tackling these challenges requires extensive exchange of data, information and knowledge between sequencing centers, bio-informatics networks, the medical research community and the industry at the European level. The GEUVADIS (Genetic EUropean VAriation in DISease) Consortium has four main aims:
1. Develop standards in quality control and assessment of sequence data
2. Develop models for sequencing data storage, access and exchange
3. Develop standards for the handling, analysis and interpretation of sequencing data from DNA (and RNA)
4. Develop guidelines on the handling of ethical, legal and social implications of phenotype prediction from sequence variation
* PURPOSE OF SURVEY
1. Collect quantitative and qualitative information on the current status of DNA sequence production, storage, exchange and analysis in Europe.
2. Collect feedback from research/clinical centers on their main challenges and difficulties regarding the management of these large data-sets potentially containing important medical information
3. Collect information on local standardization efforts, and avoid duplication of efforts throughout Europe
4. Create a road-map/policy document outlining the necessary steps to take national standards to the European level
* POTENTIAL PUBLICATION OF RESULTS
1. Results of this survey will be presented at an internal GEUVADIS workshop, on October 30-31st 2012.
2. We will disseminate the road-map to potential funders (private of public), including the European Commission and other possible national public funders.
3. We will submit an abstract to the Joint Conference of Human Genome Meeting 2013 and 21st International Congress of Genetics.
* DEADLINE: 30.09.2012
---------------------
If you have any question or comment regarding the Annual Meeting, the workshop and/or the survey please don't hesitate to contact me.
Kind regards,
Gabrielle.-
Gabrielle Bertier
Scientific Project Manager
International and Scientific Affairs
CRG, Center for Genomic Regulation
Carrer Dr. Aiguader, 88
08003 Barcelona, España
Tel: +34933160374
Mobile: +34639960656
email: gabrielle.bertier(a)crg.es<mailto:gabrielle.bertier@crg.es>
web: www.geuvadis.eu; www.fliact.eu
Hello,
Here are some badly belated minutes from last week's analysis group TC.
The next call will be this Thursday, October 11 at 2pm CET.
- There's a new conference call system of a shared screen and notes that
we can use later if we want to
- Maarten presented some early results from miRNA-mRNA correlations. The
background null distribution looks good and unbiased, and hopefully
refining the analysis a bit further will help us to get a significant
signal out of this.
- Micha presented a draft plot for the paper of how gene discoveries
increase as a function of sequenced samples
- After the main call we had a splicing subgroup call - different
splicing measures and splice scores of variants seem to correlate
nicely, there's plenty of data and analysis is going well, although
there's plenty of things to do especially wrapping up the sQTLs.
- The next call will have a splicing theme: Micha will present splice
junction analyses, and if there's time Tuuli will present
allele-specific alternative splicing. For those who are interested, I've
already updated the wiki with ASAS methods analyses
(http://sanabre.net/geuvadis/index.php/Allele_specific_alternative_splicing).
best,
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
Dear all
Please find attached a document describing an approach and initial results for miRNA:mRNA integration that Maarten van Iterson will discuss during today's TC
Peter
Dr. Peter A.C. 't Hoen
Center for Human and Clinical Genetics
Leiden University Medical Center
Postal zone S4-P
PO Box 9600
2300 RC Leiden
The Netherlands
phone: +31-71-5269421
fax: +31-71-5268285
e-mail: p.a.c.hoen(a)lumc.nl
Dear all,
This is a reminder of our TC today at 14:00 CET
Here are the details of the call:
Agenda
Analysis updates
Presentation from Leiden
After the main call we'll continue with a subgroup to discuss splicing analyses; anyone interested is welcome to stay for that too.
Dial-in
Germany 08001013982
Netherlands 0107994092
Spain 900800678
Sweden 0752400458
Switzerland 0800705347
United Kingdom 08005285280
United States 3032489677
Access code: 3160100
Dear all,
Please fill in the following doodle for the next GEUVADIS RNAseq TC on the project's publication:
http://www.doodle.com/pdeyynfz3rnwvtaf?lt=2<http://www.doodle.com/pdeyynfz3rnwvtaf?lt=1>
Preliminary agenda would be:
- outlines of the main paper and the QC companion paper
- practicalities of publication
- other companion papers
Kind regards,
Gabrielle
Gabrielle Bertier
Scientific Project Manager
International and Scientific Affairs
CRG, Center for Genomic Regulation
Carrer Dr. Aiguader, 88
08003 Barcelona, España
Tel: +34933160374
Mobile: +34639960656
email: gabrielle.bertier(a)crg.es<mailto:gabrielle.bertier@crg.es>
web: www.geuvadis.eu; www.fliact.eu